These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Frosh A; Smith LC; Jackson CJ; Linehan JM; Brandner S; Wadsworth JD; Collinge J Lancet; 2004 Oct 2-8; 364(9441):1260-2. PubMed ID: 15464187 [TBL] [Abstract][Full Text] [Related]
6. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Head MW; Ritchie D; Smith N; McLoughlin V; Nailon W; Samad S; Masson S; Bishop M; McCardle L; Ironside JW Am J Pathol; 2004 Jan; 164(1):143-53. PubMed ID: 14695328 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. Hilton DA; Ghani AC; Conyers L; Edwards P; McCardle L; Ritchie D; Penney M; Hegazy D; Ironside JW J Pathol; 2004 Jul; 203(3):733-9. PubMed ID: 15221931 [TBL] [Abstract][Full Text] [Related]
8. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Ritchie DL; Head MW; Ironside JW Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981 [TBL] [Abstract][Full Text] [Related]
9. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Jiménez-Huete A; Lievens PM; Vidal R; Piccardo P; Ghetti B; Tagliavini F; Frangione B; Prelli F Am J Pathol; 1998 Nov; 153(5):1561-72. PubMed ID: 9811348 [TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008. Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221 [TBL] [Abstract][Full Text] [Related]
11. Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment. Sachse C; Groschup MH; Warzok R; Greinacher A Eur J Haematol; 2003 Jan; 70(1):11-6. PubMed ID: 12631254 [TBL] [Abstract][Full Text] [Related]
12. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. Hilton DA; Sutak J; Smith ME; Penney M; Conyers L; Edwards P; McCardle L; Ritchie D; Head MW; Wiley CA; Ironside JW J Clin Pathol; 2004 Mar; 57(3):300-2. PubMed ID: 14990604 [TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy. Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333 [TBL] [Abstract][Full Text] [Related]
14. Investigation of PrPres in dental tissues in variant CJD. Head MW; Ritchie D; McLoughlin V; Ironside JW Br Dent J; 2003 Sep; 195(6):339-43; discussion 331. PubMed ID: 14513001 [TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical classification of human prion disease. Wadsworth JD; Hill AF; Beck JA; Collinge J Br Med Bull; 2003; 66():241-54. PubMed ID: 14522862 [TBL] [Abstract][Full Text] [Related]
16. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094 [TBL] [Abstract][Full Text] [Related]